美国前列腺癌诊断时远处转移的增加。
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.
机构信息
Department of Urology, Weill Cornell Medicine-New York Presbyterian Hospital, New York.
Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
出版信息
JAMA Oncol. 2017 May 1;3(5):705-707. doi: 10.1001/jamaoncol.2016.5465.
Abstract
This population-based study assesses the effect of the decline in prostate-specific antigen screening and incidence on prostate cancer presentation.
摘要
本基于人群的研究评估了前列腺特异性抗原筛查和发病率下降对前列腺癌表现的影响。
相似文献
1
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.美国前列腺癌诊断时远处转移的增加。
JAMA Oncol. 2017 May 1;3(5):705-707. doi: 10.1001/jamaoncol.2016.5465.
2
Increase in Prostate Cancer Metastases at Radical Prostatectomy in the United States.美国前列腺癌根治术中前列腺癌转移情况的增加。
Eur Urol. 2017 Jan;71(1):147-149. doi: 10.1016/j.eururo.2016.06.036. Epub 2016 Jul 9.
3
Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries.前列腺癌登记处中前列腺特异性抗原值的准确性。
J Clin Oncol. 2016 Oct 10;34(29):3586-3587. doi: 10.1200/JCO.2016.68.9216.
4
Prostate cancer options expand beyond the PSA.前列腺癌的治疗选择已超越前列腺特异性抗原（PSA）检测。
Clin Resour Manag. 2002 May;3(5):65-8.
5
Early-stage prostate cancer, PSA screening rates decline.早期前列腺癌，前列腺特异抗原筛查率下降。
Cancer. 2016 Mar 15;122(6):825. doi: 10.1002/cncr.29930.
6
Population-based assessment of prostate-specific antigen testing for prostate cancer in the elderly.基于人群的老年前列腺癌前列腺特异性抗原检测评估
Urol Oncol. 2015 Feb;33(2):69.e29-34. doi: 10.1016/j.urolonc.2014.06.003. Epub 2014 Jul 10.
7
Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer.前列腺特异性抗原筛查与近期高级别前列腺癌的增加。
JNCI Cancer Spectr. 2020 Oct 26;5(1). doi: 10.1093/jncics/pkaa098. eCollection 2021 Feb.
8
PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.美国预防服务工作组建议反对前列腺癌筛查后，对前列腺特异性抗原筛查、前列腺活检和前列腺癌治疗的相关情况。
Cancer. 2018 Jul 1;124(13):2733-2739. doi: 10.1002/cncr.31337. Epub 2018 May 21.
9
Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.5α-还原酶抑制剂治疗与老年男性前列腺癌死亡率的相关性。
JAMA Netw Open. 2019 Oct 2;2(10):e1913612. doi: 10.1001/jamanetworkopen.2019.13612.
10
Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.转移性乳腺癌和前列腺癌的趋势——癌症动态学的经验教训。
N Engl J Med. 2015 Oct 29;373(18):1685-7. doi: 10.1056/NEJMp1510443.
引用本文的文献
1
Trends in stage-specific prostate cancer incidence by neighborhood socioeconomic status.按社区社会经济地位划分的特定分期前列腺癌发病率趋势。
JNCI Cancer Spectr. 2025 Apr 30;9(3). doi: 10.1093/jncics/pkaf050.
2
Vasectomy and prostate cancer risk: a pooled of cohort studies and Mendelian randomization analysis.输精管切除术与前列腺癌风险：队列研究与孟德尔随机化分析的汇总
BMC Cancer. 2025 Feb 24;25(1):332. doi: 10.1186/s12885-025-13750-8.
3
Cancer statistics for African American and Black people, 2025.2025年非裔美国人和黑人的癌症统计数据。
CA Cancer J Clin. 2025 Mar-Apr;75(2):111-140. doi: 10.3322/caac.21874. Epub 2025 Feb 20.
4
PSA testing in primary care: is it time to change our practice?基层医疗中的前列腺特异性抗原检测：是时候改变我们的做法了吗？
BMC Prim Care. 2024 Dec 26;25(1):436. doi: 10.1186/s12875-024-02688-8.
5
Management considerations and treatment outcomes for newly diagnosed prostate cancer in advanced age patients (≥80 years): real-world data from a single urological center over a 10-year period.高龄患者（≥80岁）新诊断前列腺癌的管理考量与治疗结果：来自单一泌尿外科中心10年期间的真实世界数据
Transl Androl Urol. 2024 Aug 31;13(8):1506-1516. doi: 10.21037/tau-24-134. Epub 2024 Aug 26.
6
Methylated DNA Markers in Voided Urine for the Identification of Clinically Significant Prostate Cancer.用于鉴定临床显著性前列腺癌的晨尿甲基化DNA标志物
Life (Basel). 2024 Aug 18;14(8):1024. doi: 10.3390/life14081024.
7
The Influence of Disparities on Prostate Cancer at Diagnosis in the Charlotte Metropolitan Area.夏洛特都会区诊断时前列腺癌的差异影响。
Ann Surg Oncol. 2024 Nov;31(12):8394-8404. doi: 10.1245/s10434-024-15675-1. Epub 2024 Jul 30.
8
Impact of the COVID-19 Pandemic on Prostate Cancer Diagnosis, Staging, and Treatment: A Population-Based Study in Northern Italy.新冠疫情对前列腺癌诊断、分期及治疗的影响：意大利北部一项基于人群的研究
Biology (Basel). 2024 Jul 4;13(7):499. doi: 10.3390/biology13070499.
9
Prostate cancer among Saudis: a registry review.沙特人中的前列腺癌：一项登记研究回顾
Ann Med Surg (Lond). 2023 Nov 7;86(1):56-61. doi: 10.1097/MS9.0000000000001448. eCollection 2024 Jan.
10
Impacts on functional and oncological outcomes of Robotic-assisted Radical Prostatectomy 10 years after the US Preventive Service Taskforce recommendations against PSA screening.美国预防服务工作组建议停止 PSA 筛查 10 年后，机器人辅助根治性前列腺切除术对功能和肿瘤学结果的影响。
Int Braz J Urol. 2024 Jan-Feb;50(1):65-79. doi: 10.1590/S1677-5538.IBJU.2023.0530.
本文引用的文献
1
Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening.美国预防服务工作组建议停止筛查后两年的前列腺癌发病率
JAMA Oncol. 2016 Dec 1;2(12):1657-1660. doi: 10.1001/jamaoncol.2016.2667.
2
Reevaluating PSA Testing Rates in the PLCO Trial.重新评估前列腺、肺、结直肠癌和卵巢癌筛查试验（PLCO）中的前列腺特异性抗原（PSA）检测率
N Engl J Med. 2016 May 5;374(18):1795-6. doi: 10.1056/NEJMc1515131.
3
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查：美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
4
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
Zotero 插件